BNTC (Benitec Biopharma) Cyclically Adjusted FCF per Share: $-47.74 (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.21
View Full Analysis

What is Benitec Biopharma Cyclically Adjusted FCF per Share?

Benitec Biopharma BNTC +4.34% 34 Cyclically Adjusted FCF per Share is $-47.74 as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Benitec Biopharma's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.090. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-47.74 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-03), Benitec Biopharma's current stock price is $13.21. Benitec Biopharma's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-47.74. Benitec Biopharma's Cyclically Adjusted Price-to-FCF of today is .


Benitec Biopharma  (NAS:BNTC) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Benitec Biopharma Cyclically Adjusted FCF per Share Related Terms


Benitec Biopharma Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Cyclically Adjusted FCF per Share Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -54.67 -50.58

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -51.42 -50.58 -49.53 -47.87 -47.74

BNTC vs IPSC, FBRX, AUTL: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Benitec Biopharma's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benitec Biopharma Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Cyclically Adjusted Price-to-FCF falls into.


BNTC
34GF Score
Benitec Biopharma Inc BNTC
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Benitec Biopharma's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.09/330.2130*330.2130
=-0.090

Current CPI (Mar. 2026) = 330.2130.

Benitec Biopharma Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -2.162 241.018 -2.962
201609 -7.180 241.428 -9.820
201612 -4.285 241.432 -5.861
201703 1.817 243.801 2.461
201706 -2.544 244.955 -3.429
201709 -3.028 246.819 -4.051
201712 -4.895 246.524 -6.557
201803 0.421 249.554 0.557
201806 -48.250 251.989 -63.228
201809 6.820 252.439 8.921
201812 -29.118 251.233 -38.272
201903 1.525 254.202 1.981
201906 -40.060 256.143 -51.644
201909 -10.686 256.759 -13.743
201912 -50.426 256.974 -64.798
202003 -12.206 258.115 -15.615
202006 -48.385 257.797 -61.977
202009 -38.969 260.280 -49.439
202012 -13.834 260.474 -17.538
202103 -7.183 264.877 -8.955
202106 -10.428 271.696 -12.674
202109 -8.894 274.310 -10.707
202112 -6.952 278.802 -8.234
202203 -7.114 287.504 -8.171
202206 -10.094 296.311 -11.249
202209 -6.330 296.808 -7.042
202212 -3.605 296.797 -4.011
202303 -2.448 301.836 -2.678
202306 -2.489 305.109 -2.694
202309 -2.122 307.789 -2.277
202312 -2.083 306.746 -2.242
202403 -0.337 312.332 -0.356
202406 -0.128 314.175 -0.135
202409 -0.164 315.301 -0.172
202412 -0.207 315.605 -0.217
202503 -0.080 319.799 -0.083
202506 -0.200 322.561 -0.205
202509 -0.081 324.800 -0.082
202512 -0.082 324.054 -0.084
202603 -0.090 330.213 -0.090

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-47.74 mean?
Benitec Biopharma (BNTC) has a Cyclically Adjusted FCF per Share of $-47.74 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Cyclically Adjusted FCF per Share too high?
Benitec Biopharma's current Cyclically Adjusted FCF per Share is $-47.74. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Cyclically Adjusted FCF per Share compare to IPSC and FBRX?
Benitec Biopharma's Cyclically Adjusted FCF per Share of $-47.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Cyclically Adjusted FCF per Share is $-47.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Cyclically Adjusted FCF per Share of $-47.74. The current Cyclically Adjusted FCF per Share is $-47.74. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Cyclically Adjusted FCF per Share is $-47.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.21
Price